Immediate Impact

2 by Nobel laureates 3 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
1 intermediate paper

Works of P. Massarenti being referenced

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
2004

Author Peers

Author Last Decade Papers Cites
P. Massarenti 153 98 17 317 139 16 665
Vicki Morgan‐Stevenson 68 144 10 403 123 13 782
Nancy Hua 71 268 14 243 254 8 849
Musa Bali 87 117 66 95 57 40 662
David Orr 58 104 27 244 44 14 626
Alba Berlanga 38 204 8 438 188 17 771
G Buonanno 44 198 4 176 445 19 815
Mizuko Osaka 39 118 33 165 90 23 669
Derya Koçer 62 66 127 180 288 37 832
A Austin 40 131 9 551 338 21 821
Nadia Bortolotti 90 183 97 131 227 17 685

All Works

Loading papers...

Rankless by CCL
2026